Mindful Breaths: Mindfulness for Young Adult Vaping
Launched by TULANE UNIVERSITY · Oct 1, 2024
Trial Information
Current as of July 04, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The "Mindful Breaths: Mindfulness for Young Adult Vaping" clinical trial is looking to see if mindfulness techniques can help young adults aged 18 to 29 quit or reduce their vaping. Specifically, the study will explore whether practicing mindfulness can lessen nicotine cravings and whether this approach is something young adults find acceptable and helpful. Participants will be divided into two groups: one will practice a short mindfulness meditation, while the other will watch a calming video. After the sessions, everyone will share how they felt about their cravings and the experience.
To join the study, participants need to be young adults in the U.S. who vape nicotine at least 25 days a month and want to cut back or quit. They should also be comfortable reading and speaking English. People who are currently using other nicotine products, have severe mental health issues, or are already in treatment for quitting smoking or vaping won't be eligible. The study is not yet recruiting participants, but it's a great opportunity for those who want to explore a mindful approach to quitting vaping.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Young adults aged 18-29 years old
- • Residing in the United States
- • Able to read and speak English
- • Vape nicotine at least 25 days/month,
- • Interested in cutting down or quitting vaping in the next 30 days (rated at least a 5 on a 10-point scale).
- Exclusion Criteria:
- • Using any nicotine-containing products other than e-cigarettes
- • A current or past Diagnostic and Statistical Manual of Mental Disorders (DSM-5) psychiatric diagnosis of severe mental illness
- • A current DSM diagnosis of substance use disorders other than tobacco use disorder
- • Involved in regular mindful practice
- • Undergoing current smoking/vaping cessation treatment (counseling and/or medication)
- • Taking any medications that may potentially affect nicotine craving, consumption, or mood within the past 30 days.
About Tulane University
Tulane University, a prestigious institution located in New Orleans, Louisiana, is dedicated to advancing medical research and improving public health through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Tulane leverages its extensive resources and expertise in various fields, including tropical medicine, infectious diseases, and population health. The university's commitment to ethical research practices and patient-centered approaches ensures that clinical trials conducted under its auspices not only contribute to scientific knowledge but also prioritize the well-being of participants. As a leader in clinical research, Tulane University aims to translate findings into tangible health solutions that benefit local communities and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported